NHS Greater Glasgow & Clyde, Renfrew Health and Social Care Centre, 10 Ferry Road, Renfrew, PA4 8RU, United Kingdom.
School of Pharmacy and Life Sciences, Robert Gordon University, Sir Ian Wood Building, Robert Gordon University, Garthdee Road, Aberdeen, United Kingdom.
Int J Clin Pharm. 2022 Jun;44(3):663-672. doi: 10.1007/s11096-022-01387-7. Epub 2022 Mar 23.
Background General practice in the UK is experiencing a crisis. Greater multidisciplinary working is a potential solution. The new general practice contract in Scotland encourages this and includes a new pharmacotherapy service to be delivered by General Practice Clinical Pharmacists (GPCPs). Consensus is lacking for the standards of practice for delivery of pharmacotherapy medication reviews (which are polypharmacy and chronic medication reviews) as part of this service. Aim To identify and validate standards of practice for polypharmacy and chronic disease medication (pharmacotherapy level 3) reviews conducted by GPCPs. Method A two-phased mixed-methods consensus methodology was used. Phase 1: An expert group of GPCPs (n = 4) and clinical pharmacist managers (n = 2) responsible for delivering the pharmacotherapy service used a Modified Nominal Group Technique to generate potential standards. Phase 2: Two-round Delphi survey involving GPCPs with ≥ 1 year of experience of working in general practice (n = 159). Results The expert group identified 44 potential standards of practice for polypharmacy and chronic disease reviews. Practicing GPCPs indicated during the Delphi phase that the 44 standards were applicable to practice. The standards of practice covered seven main categories: skills, environment, qualifications, qualities and behaviours, knowledge, process and experience. Conclusion Practicing GPCPs indicated that the standards identified by the expert group are acceptable and valid for current practice and the delivery of polypharmacy and chronic medication reviews. The application of these standards to practice may help GPCPs and general practices to ensure equitable delivery of patient care.
英国的全科医学正面临危机。更多的多学科合作是潜在的解决方案。苏格兰新的全科医生合同鼓励这种合作，并包括由全科临床药剂师（GPCP）提供的新的药物治疗服务。对于作为该服务一部分的药物治疗药物评估（包括复方药物和慢性病药物评估）的实践标准，尚未达成共识。目的：确定并验证 GPCP 进行复方药物和慢性病药物（药物治疗 3 级）评估的实践标准。方法：采用两阶段混合方法共识方法。第 1 阶段：负责提供药物治疗服务的 GPCP（n=4）和临床药剂师经理（n=2）的专家组使用改良名义小组技术生成潜在标准。第 2 阶段：涉及具有至少 1 年在全科实践中工作经验的 GPCP（n=159）的两轮 Delphi 调查。结果：专家组确定了 44 项复方药物和慢性病评估的潜在实践标准。在 Delphi 阶段，执业 GPCP 表示这些 44 项标准适用于实践。实践标准涵盖了七个主要类别：技能、环境、资格、素质和行为、知识、过程和经验。结论：执业 GPCP 表示专家组确定的标准适用于当前实践，并且可用于提供复方药物和慢性病药物评估。将这些标准应用于实践可能有助于 GPCP 和全科医生确保公平地提供患者护理。
